CTRI/2008/091/000195已完成2 期
Phase II/III Randomized Placebo Controlled Clinical Trial of Curcumin in Resectable Stage III and IV Squamous Head and Neck Cancers (Oral cancers)
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- DBT
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically confirmed squamous cancers of oral cavity
- •2. Stage III-IV (resectable lesions)
- •3. Karnofsky?s scale > 60%
- •4. Patients selected to undergo curative treatment (otherwise generally fit patients)
- •5. Patient has signed and dated the Informed Consent Document
- •6. Patient is willing and able to fully participate for the duration of the study
排除标准
- •1. All patients with unresectable lesions
- •2. Poor Karnofsky?s scale
- •3. Patients with non-squamous cancers.
- •4. Patients who does not comply with assigned
- •complete treatment protocol.
- •5. Patients with potential behavior and cognitive
- •impairment.
研究者
相似试验
进行中（未招募）
1 期
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with SarcopeniaEUCTR2007-002383-95-FRaboratoires Merck Sharp & Dohme- Chibret200
进行中（未招募）
不适用
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy andSafety of MK-0773 in Patients with Sarcopenia. - NDEUCTR2007-002383-95-ITMerck & Co., Inc.200
进行中（未招募）
不适用
A Phase IIa Randomized, Placebo-Controlled Clinical Trial toStudy the Efficacy and Safety of MK-0773 in Patients withSarcopenia - Sarcopenia StudySarcopeniaMedDRA version: 9.1Level: LLTClassification code 10063024Term: SarcopeniaEUCTR2007-002383-95-DKMerck & Co., Inc.200
进行中（未招募）
1 期
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with Sarcopenia - Sarcopenia StudySarcopeniaMedDRA version: 9.1 Level: LLT Classification code 10063024 Term: SarcopeniaEUCTR2007-002383-95-GBMerck & Co Inc.,200
进行中（未招募）
1 期
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with Sarcopenia Ensayo en fase IIa aleatorizado y controlado con placebo para estudiar la eficacia y la seguridad de MK 0773 en pacientes con sarcopenia - Sarcopenia StudySarcopeniaMedDRA version: 9.1 Level: LLT Classification code 10063024 Term: SarcopeniaEUCTR2007-002383-95-ESMerck Sharp & Dohme de España, S.A.200